Inection Point Acquisition Corp. VII

Inection Point Acquisition Corp. VII

NNASDAQ:IPXG
10.21
USD
-0.01
(-0.15%)
0.04EPS
244.72P/E
317.70MMarket Cap
Mar 03Next Earn

Total Valuation

USD

As of June 30, 2026, Inection Point Acquisition Corp. VII carries a market capitalization of 317.70M, placing it among publicly traded companies globally. Its enterprise value stands at 316.62M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap317.70M
Enterprise Value316.62M

Important Dates

Inection Point Acquisition Corp. VII's next confirmed earnings release is scheduled for March 3, 2027.

Earnings Date3/3/2027

Share Statistics

As of June 30, 2026, Inection Point Acquisition Corp. VII has 31.33M shares outstanding.

Shares Outstanding31.33M

Valuation Ratios

As of June 30, 2026, Inection Point Acquisition Corp. VII trades at a trailing price-to-earnings ratio of 244.72.

PE Ratio244.72
PB Ratio1.36
P/TBV Ratio1.36
P/FCF Ratio-769.76
P/OCF Ratio-766.58

Financial Position

As of June 30, 2026, Inection Point Acquisition Corp. VII maintains a current ratio of 0.79, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

Current Ratio0.79
Quick Ratio0.68

Financial Efficiency

These figures cover the twelve months ended June 30, 2026. The company generates approximately - - in revenue per employee across its workforce of 2.00, a quick read on workforce productivity versus industry peers.

Employee Count2.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Inection Point Acquisition Corp. VII's stock has declined approximately 4.00% over the past 52 weeks. The 50-day moving average sits at 10.11, while the 200-day moving average is 10.17.

52-Week Price Change-4.00%
50-Day Moving Average10.11
200-Day Moving Average10.17

Income Statement

USD

Over the twelve months ended June 30, 2026, Inection Point Acquisition Corp. VII generated - - in revenue and converted that into 1.18M in net income, yielding earnings per share of 0.04. EBITDA reached -1.92M, while operating income came in at -1.92M.

Operating Income-1.92M
Pretax Income1.18M
Net Income1.18M
EBITDA-1.92M
EBIT-1.92M
Earnings Per Share (EPS)0.04

Balance Sheet

USD

These figures are as of June 30, 2026. Total book value stands at 232.83M, with working capital of -343,967.00 providing operational flexibility.

Cash & Cash Equivalents1.09M
Net Debt-1.09M
Equity (Book Value)232.83M
Book Value Per Share7.43
Working Capital-343,967.00

Cash Flow

USD

Inection Point Acquisition Corp. VII produced -375,953.00 in operating cash flow over the twelve months ended June 30, 2026.

Operating Cash Flow-375,953.00
Free Cash Flow-375,953.00
FCF Per Share-0.01

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -0.13: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

FCF Yield-0.13

Scores

As of June 30, 2026, Inection Point Acquisition Corp. VII has an Altman Z-Score of 118.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score118.73